New publications in health economics and genomics 25th January 2022

Two publications from the past week:

  • Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision Oncology | link
  • Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 18th January 2022

Two publications from the past week:

  • Developing new frameworks to value genomic information: accounting for complexity | link
  • Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 4th January 2022

A bumper crop of publications from the holiday period:

  • Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases | link
  • The complexity of diagnosing rare disease: An organizing framework for outcomes research and health economics based on real-world evidence | link
  • Economic evaluations of exome and genome sequencing in pediatric genetics: considerations towards a consensus strategy | link
  • Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients | link
  • Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization | link
  • The cost-effectiveness of genotyping versus sequencing for prenatal cystic fibrosis carrier screening | link
  • Precision medicine testing in ovarian cancer: The growing inequity between patients with commercial vs medicaid insurance | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 7th December 2021

One publication from the past week:

  • Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 30th November 2021

One publication from the past week:

  • Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 23rd November 2021

Two publications from the past week:

  • The diagnostic trajectory of infants and children with clinical features of genetic disease | link
  • Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 16th November 2021

Three publications from the past week:

  • Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis | link
  • 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report | link
  • Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 2nd November 2021

Three publications from the past week:

  • Incomplete information and irrelevant attributes in stated-preference values for health interventions | link
  • The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group | link
  • Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 26th October 2021

Three publications from the past week (there were no publications in the rest of October, hence the radio silence!):

  • Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine | link
  • The Value of Genomic Testing: A Contingent Valuation Across Six Child- and Adult-Onset Genetic Conditions | link
  • Conceptualization of utility in translational clinical genomics research | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 28th September 2021

Two publications from the past week:

  • Evaluating genetic and genomic tests for heritable conditions in Australia: lessons learnt from health technology assessments | link
  • Comprehensive genomic profiling for non-small-cell lung cancer: health and budget impact | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.